Interested in the RFP for the Innovative Methodologies and New Data for Predictive Oncology Model Evaluation (IMPROVE) project?
Register for the Project Bidders Conference on April 6, 2022, 3 p.m. to 4:30 p.m., ET!
What is IMPROVE?
IMPROVE is a new National Cancer Institute and Department of Energy (NCI/DOE) Collaboration project focused on improving deep learning models to predict the efficacy of cancer treatments. The overall goal of this project is to engage the broader research community to produce a generalizable and extensible framework for comparing and improving AI models of therapeutic response in a subset of cancer model systems.
The NCI/FNLCR and DOE intend to extensively collaborate with the extramural research community to identify, curate, and test models predicting therapeutic efficacy as well as understanding how models fail and undertaking a systematic evaluation of the value of the various data types in relation to their cost and patient impact.
This RFP focuses on Aim 1: IMPROVE Model Comparison: development of semi-automatic protocols for comparing cancer therapeutic response deep learning models and identifying model attributes that contribute to prediction performance with the goal of IMPROVING future models.
Note: A separate RFI has been issued for Aim 2: IMPROVE Model Performance: development of protocols for designing drug and therapeutic screening experiments to generate data explicitly aimed at IMPROVING deep learning model performance. Details can be found here.
Who Should Attend:
Individuals and teams interested in responding to the IMPROVE RFP, including the following: U.S. and international cancer researchers; AI researchers and mathematical modelers—including mechanistic, data-driven and multi-scale modelers and others with a demonstrated record of building, testing and deploying AI in the cancer space or other related therapeutic areas. Clinicians, oncologists, biomedical engineers, bioinformaticians, data scientists, computer scientists, medical physicists, physician scientists, pathologists, patient advocates, policy makers, software engineers/architects, and surgical oncologists are invited to attend, but awardees must have a demonstrated record in the relevant fields and be able to bid all subtasks.
Participants are encouraged to submit their questions in advance by emailing IMPROVE-AI@nih.gov. Questions submitted in advance will be answered at the Bidders Conference.
Date of the Bidders Conference: April 6, 2022, 3:00 p.m. to 4:30 p.m. ET
Where: Virtual, no need to travel
Register Now » Registration deadline: 5 p.m., ET – Tuesday, April 5, 2022.
For more information, visit the event site.
Questions? Contact IMPROVE-AI@nih.gov.
Please forward this invitation to colleagues who may be interested!